Shielding effect of a PEG molecule of a mono-PEGylated peptide varies with PEG chain length.
Prep Biochem Biotechnol · 2018
Last updated 2026-05-28Researchers tested how attaching different lengths of PEG molecules (5, 10, 20, and 40 kilodaltons) to exenatide—a GLP-1 drug—affected its electrical charge and behavior in lab tests. They found that longer PEG chains blocked the drug’s electrical interactions over a larger area, shielding up to 5, 8, 12, or 17 amino acids (depending on the PEG size) on either side of the attachment point.
AI summary of the abstract below.
| Journal | Prep Biochem Biotechnol, 2018 |
|---|---|
| Citations | 15 |
| Relative citation ratio | 0.79 |
| NIH percentile | 43 |
| Molecules | — |
Abstract
'Shielding' effect of a conjugated PEG molecule could cause a change in the electrostatic interaction characteristics of a PEGylate. We investigated how PEG chain length (or molecular weight) alters the electrostatic interaction potential of exenatide variants using their mono-PEGylates in a branched and linear form as model PEGylates. First, we performed the experiments to demonstrate the elution time changes of the mono-PEGylates conjugated with various MW PEGs (5, 10, 20, and 40 kD) using cation exchange chromatography (HiTrap SP) at various pHs (2.5, 3.0, 3.5, and 4.0). Then, we calculated the net surface charge of each mono-PEGylate to propose the PEG molecule's shielding range in terms of the number of amino acids adjacent to the conjugation residue, assuming that a PEG molecule in solution sweeps out a spherical space and an exenatide molecule have a secondary structure. The net charge calculation result was well-correlated with the experimental elution time data, where 5, 10, 20, and 40 kD PEG hindered the electrostatic potential of 5, 8, 12, and 17 amino acid residues in maximum, respectively, on each side of the conjugation point.
Verbatim abstract via PubMed 29932808 ↗